PARP1/EZH2-IN-1
PARP1/EZH2-IN-1 is a selective PARP1 and EZH2 dual inhibitor. PARP1/EZH2-IN-1 has IC50s of 28 nM, 414 nM and 74 nM for PARP1, PARP2 and EZH2, respectively. PARP1/EZH2-IN-1 inhibits the proliferation and migration of TNBC cells (triple-negative breast Cancer cells). PARP1/EZH2-IN-1 induces PANoptosis (Apoptosis, Pyroptosis and Necroptosis), increases the level of reactive oxygen species (ROS), and activates related inflammatory pathways. PARP1/EZH2-IN-1 can be used in triple-negative breast cancer research.
For research use only. We do not sell to patients.
- Formula: C39H43ClN8O4
- Molecular Weight:723.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Histone Methyltransferase Isoforms
More
Biological Activity
Description
IC50 & Target
|
PARP-1 28 nM (IC50) |
PARP2 414 nM (IC50) |
EZH2 74 nM (IC50) |
In Vitro
PARP1/EZH2-IN-1 (compound PE32) (72 h) has IC50 of 2.85 μM, 1.83 μM and 1.46 μM for MDA-MB-231, MDA-MB-468 and BT-549, respectively[1].
PARP1/EZH2-IN-1 (1.0-2.0 μM, 24 h) demonstrates stronger inhibitory effects on BT-549 cells invasion, migration, and scratch-wound repair[1].
PARP1/EZH2-IN-1 (0.5-2.0 μM, 48 h) inhibits the proliferation and growth of MDA-MB-231, BT-549 cells[1].
PARP1/EZH2-IN-1 (2.0 μM, 48 h) leads to intensified DNA damage and disrupts the homologous recombination repair pathway in BT-549 cells[1].
PARP1/EZH2-IN-1 (1.5 μM, 48 h) causes the death of BT-549 cells by inducing apoptosis and pyroptosis of the cells[1].
PARP1/EZH2-IN-1 (0.625-10 μM, 48 h) exerts the antitumor effect primarily through triggering a ROS burst in BT-549 cells[1].
PARP1/EZH2-IN-1 enriches tumor-related death pathways, including transcriptional misregulation in cancer, ECM-receptor interaction, and TNF signaling, activates key inflammatory pathways, such as IL-17 and NF-κB, and induces tumor cell pyroptosis through activating these critical inflammatory signaling cascades[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:BT-549 cells
-
Concentration:1.0, 1.5 and 2.0 μM
-
Incubation Time:24 h
-
Result:Inhibited the invasion of TNBC cells.
Suppressed cell migration in scratch-wound repair.
-
Cell Line:BT-549 cells
-
Concentration:1.0, 1.5 and 2.0 μM
-
Incubation Time:24 h
-
Result:Inhibited the invasion of TNBC cells.
Suppressed cell migration in scratch-wound repair.
Exhibited a stronger inhibitory effect on TNBC cells
-
Cell Line:BT-549 cells
-
Concentration:2.0 μM
-
Incubation Time:48 h
-
Result:Decreased the expression levels of PAR, H3K27me3, BRCA1 and RAD51 proteins.
Increased the expression level of γ-H2AX.
-
Cell Line:TNBC cell
-
Concentration:0.625, 1.25, 2.5, 5, 10 μM
-
Incubation Time:48 h
-
Result:Suppressed TNBC cell viability in a manner dependent on ROS accumulation, as evidenced by the significant reversal of this effect upon co-treatment with the ROS scavenger NAC.
Parmacokinetics
| Species | Dose | Route | C0 | AUC0-t | AUC0-∞ | T1/2 | Vd/F | CL/F | MRT0-∞ |
|---|---|---|---|---|---|---|---|---|---|
| Rat | 2 mg/kg | i.v. | 9.92 mg/L | 0.89 mg·h/L | 0.92 mg·h/L | 0.44 h | 1.36 L/h/kg | 2172 L/h/kg | 0.08 h |
Chemical Information
-
Molecular Weight 723.26
-
Formula C39H43ClN8O4
-
SMILES
CCC1=CC(N=CC(CN2CCN(C3=NC=C(C4=CC(N(C(CCl)=O)CC)=CC(C(NCC5=C(C)C=C(C)NC5=O)=O)=C4)C=C3)CC2)=C6)=C6NC1=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)